4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-029971
Chief Commercial Officer gave up 2,461 shares (to pay taxes)
- Chief Commercial Officer acquired 125,950 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Gayer Charles K · Chief Commercial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-19 | Grant or award : show line 1 in the form | +125,950 | 426,007 | D | ||
| 2024-12-19 | Shares withheld for taxes : show line 2 in the form | −2,461 | $7.39 | $18,187 | 423,546 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-19 | Grant or award : show line 3 in the form Emp. Stock Option (Right to Buy) | +260,950 | 260,950 | D |
Loading xslF345X05/form4.xml…